Marinomed Biotech AG Grants Exclusive Rights for Carragelose® to M8 Pharmaceuticals marketed locally as Barlo® ...Middle East

M8 Pharmaceuticals to obtain exclusive rights for marketing Carragelose® in Brazil and Mexico Carragelose® nasal spray has clinically demonstrated high efficacy against multiple viruses of the upper respiratory tract Carragelose®- containing products will be marketed under the tradename...

Hence then, the article about marinomed biotech ag grants exclusive rights for carragelose to m8 pharmaceuticals marketed locally as barlo was published today ( Tuesday 06/07/2021 - 07:00 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Marinomed Biotech AG Grants Exclusive Rights for Carragelose® to M8 Pharmaceuticals marketed locally as Barlo® )

Also on site :

• Hundreds of flights delayed at O'Hare after pipe burst at air traffic control tower
• Two dead in floods & torrential rains sweeping through Tunisia
• ‘High School Musical’ Turns 20 Today! See Where the Cast Is Now